Table 2.
Correlation coefficients (r2) from each measure with CTTOT for in vivo and computational model simulations
r2 | In Vivo (61) | In Vivo (Present) | Base Model (48) | Version 1 | Version 2 |
---|---|---|---|---|---|
I amplitude | 0.07 | <0.01 | 0.50* | 0.05 | 0.11 |
E amplitude | 0.11 | 0.01 | 0.50* | <0.01 | 0.15 |
CTI | 0.24 | 0.10 | 0.70* | 0.55* | 0.14 |
CTE1 | 0.09 | <0.01 | 0.60* | 0.52* | 0.05 |
CTE2 | 0.89* | 0.79* | 0.85* | 0.68* | 0.93* |
In vivo (61), in vivo data from Wang et al. (61); the base model is from Poliaček et al. (48). Note the strong association between CTTOT and the duration of the second expiratory phase (CTE2) in the in vivo conditions. Version 2 is the only model that predicted this important in vivo interaction and did not predict association of other measures with CTTOT.
Moderate and strong associations.